| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |